Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,457 | -83,440 | -29,365 | 58,037 | -29,943 |
| Depreciation Amortization | 4,273 | 4,254 | 2,551 | 2,815 | 3,584 |
| Accounts receivable | -3,099 | 25 | -1,133 | 523 | -1,006 |
| Other Working Capital | 13,479 | 27,246 | 1,124 | -3,286 | -2,226 |
| Other Operating Activity | 4,062 | 41,921 | -5,275 | -82,373 | 310 |
| Operating Cash Flow | $-7,742 | $-9,994 | $-32,098 | $-24,284 | $-29,281 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 62 | -146 | -106 | 45 | -90 |
| PPE Investments | -686 | -968 | -829 | -461 | -774 |
| Other Investing Activity | 33 | -5 | -32 | 39,803 | -137 |
| Investing Cash Flow | $-591 | $-1,119 | $-967 | $39,387 | $-1,001 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 9,542 | 19,681 | N/A | N/A |
| Debt Repayment | -4,752 | -10,961 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 14 | 6,635 | 46 |
| Financing Cash Flow | $-4,752 | $-1,419 | $19,695 | $6,635 | $46 |
| Exchange Rate Effect | -270 | 414 | 277 | -131 | -1,395 |
| Beginning Cash Position | 51,163 | 63,281 | 76,374 | 54,767 | 86,398 |
| End Cash Position | 37,808 | 51,163 | 63,281 | 76,374 | 54,767 |
| Net Cash Flow | $-13,355 | $-12,118 | $-13,093 | $21,607 | $-31,631 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,742 | -9,994 | -32,098 | -24,284 | -29,281 |
| Capital Expenditure | -686 | -971 | -849 | -464 | -785 |
| Free Cash Flow | -8,428 | -10,965 | -32,947 | -24,748 | -30,066 |